# A Study of Ferric Citrate to Improve Inflammation and Lipid Levels

> **NCT02661295** · PHASE4 · TERMINATED · sponsor: **Winthrop University Hospital** · enrollment: 38 (actual)

## Conditions studied

- End Stage Renal Disease
- Hyperphosphatemia
- Chronic Inflammation

## Interventions

- **DRUG:** Ferric Citrate

## Key facts

- **NCT ID:** NCT02661295
- **Lead sponsor:** Winthrop University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-07
- **Primary completion:** 2017-09-29
- **Final completion:** 2018-03-15
- **Target enrollment:** 38 (ACTUAL)
- **Why stopped:** 38 enrolled, 19 completed the study when loss of funding occurred
- **Last updated:** 2023-04-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02661295

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02661295, "A Study of Ferric Citrate to Improve Inflammation and Lipid Levels". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02661295. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*